Clinical Trial to test the effectiveness of siddha medicine Amukkara Chooranam (Internal) & Sangamver Thailam (External) for the disease Venpulli (Vitiligo) in children

An Open Non-Randomized Single Arm Single Centric Clinical Trial to Evaluate the Effectiveness of Amukkara Chooranam (Internal) & Sangamver Thailam (External) in the management of Venpulli (Vitiligo) in children - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/055194

Enrollment

Registered

2023-07-13

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: Amukkara Chooranam Sangamver Thailam: Amukkara Chooranam Dose: 5-7 years: 500 mg 8-12 years: 750 mg Frequency: twice a day after food Route of administration: Oral route Adjuvant: Ghe

Eligibility

Inclusion criteria

Inclusion criteria: Children of both sex in the age group of 5to 12 years with symptoms of hypo pigmented patches without any structural changes in any part of the body Patient’s parent/ informant willing to sign the informed consent stating that he/she will consciously stick to the treatment during 60 days but can opt out of the trial of his/her own conscious discretion Willing to cooperate for taking photographs whenever required with his/her consent

Exclusion criteria

Exclusion criteria: Albinism Leprosy Burns scar

Design outcomes

Primary

Measure	Time frame
Effectiveness of the trial drug is measured by VETI ScoreTimepoint: 60 days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr K Suresh

National Institute of Siddha

smilinsherry96@gmail.com9489364878

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026